pharma jobs

Latest Headlines

Latest Headlines

News flash for biopharma bosses: More than half your employees want to leave

Biopharma employee looking for a new job? You're not alone. In fact, you're not even in the minority, a new report says.

Want a Big Pharma job? Apply in an emerging market--or think smaller

Where have all the Big Pharma jobs gone? To emerging markets, for one. For another? The world's biggest drugmakers have shuffled their decks, with some shedding jobs and others gaining. Any guesses which? We'll get to that.

Who gets the likes when it comes to job hunting? Think J&J, Novartis and Biogen Idec

With all of the pharma layoffs, lots of folks are looking for a job in the industry. So where are the best places to work?

Need a job? J&J, Novartis and Biogen Idec are pharma's favorite employers

With all of the pharma layoffs, lots of folks are looking for a job in the industry. So where are the best places to work? Johnson & Johnson and Novartis if you want to work for a large company. Biogen Idec, Gilead or perhaps Novo Nordisk if you prefer more of a midsize drugmaker.

Europe may be austere, but it's also hiring in pharma

According to a report from corporate recruiters ZRG Partners, the biggest increase in pharma hiring for the first quarter came in the Austerity-R-Us region, Europe.

GSK to build new U.K. site, create up to 1,000 jobs

GSK said it will build a new facility in Ulverston, Cumbria, to boost production of ingredients for its meds and vaccines.

Novartis staffers stop work at Nyon plant in jobs protest

Swiss workers haven't taken Novartis' ($NVS) job-cutting plans lying down. First, union members and political activists joined protests in Basel--including one at Chairman Daniel Vasella's (photo)

No new cost-cutting, Roche chairman pledges

For Roche, 4,800 job cuts is enough. That's what Chairman Franz Humer told a Swiss newspaper over the weekend. Humer said the Basel-based company's current cost-squeezing program will suffice,

Integrating Cephalon, Teva eyes up to 1,500 job cuts

Hard on the heels of its merger with Cephalon, Teva Pharmaceutical Industries ($TEVA) is sharpening its jobs axe. Israeli news sources report anywhere from 1,000 to 1,500 cuts, with most of the

Sanofi plans hundreds more U.S. job cuts in sales, R&D

In yet another pharma-layoffs development, hundreds of U.S. Sanofi employees will lose their jobs over the next several months as the company absorbs Genzyme ($GENZ) and prepares for loss of